March 26, 2020 / 10:36 AM / 2 months ago

BRIEF-Briacell Continues Clinical Operations Amidst Covid-19 Pandemic

March 26 (Reuters) - Briacell Therapeutics Corp:

* BRIACELL CONTINUES CLINICAL OPERATIONS AMIDST COVID-19 PANDEMIC

* BRIACELL THERAPEUTICS - PHASE I/IIA CLINICAL STUDY OF BRIA-IMT™, WITH INCYTE’S IMMUNE CHECKPOINT INHIBITOR, INCMGA00012, IS ONGOING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below